System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Studies

Observational Recruiting

NCT05277792 on ClinicalTrials.gov

Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients

  • Sponsor: Centre Hospitalier Universitaire de Rennes
  • Enrollment: 48 (Estimated)
  • Study start: 2022-05-08 (Actual)
  • Primary completion: 2024-06-08 (Estimated)
  • Study completion: 2024-06-08 (Estimated)
  • Allocation: N/a
  • InterventionModel: N/a
  • Masking: None
  • PrimaryPurpose: Other

Brief Summary

The purpose of this study is to evaluate if concentration of tacrolimus metabolites is increased in patients presenting tacrolimus (TAC) side effects.

Conditions

  • Blood Concentration of Tacrolimus Metabolites

Primary Outcome Measures

  • Comparison of blood concentration of TAC metabolites between patients presenting TAC related side effects or not. (Day 5)

Countries

France

Locations and Investigators